PharmaBoardroom

Interview with Alberto Aleotti, Chairman & CEO, Menarini

After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most…

Interview with Jeung-Soo Kim, President, Korea Pharmaceutical…

Could you please introduce KPMA and explain the role it plays within the South Korean pharmaceutical industry? KPMA is the only association in South…

Interview with Seokmin Yoon, President, ADM Korea

How did you first get involved in clinical trials and what inspired you to create your own CRO, ADM Korea? When I was working at CJ, the company was…

Interview with In-Chull Kim, CEO, LG Life Sciences

LG Life Sciences seems quite unique among the rest of pharmaceutical companies in Korea which tend to be family owned. How has this set LGLS apart in…

Interview with Germano Carganico, General Manager, Toscana Life…

Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science…

Interview with Byoung Jai / Jae Hoon Kim Kim / Kim,…

Could you introduce Lee & Ko to our readers? Established in 1977, Lee & Ko is the largest and the leading law firm in Korea, consisting of…

Interview with Fabio Scaccio, Founder & Sale Administrator,…

Finderm is the result of a courageous entrepreneurial experience, since you initiated the operations in 1995, in the most challenging times for the…

Interview with Young Jack Lee, President, LSK Global PS

South Korea has a short history of participating in global clinical trials, but now the country is seeing exponential growth in this area. What has…

Interview with Jong-Wook Lee, CEO, Daewoong Pharmaceutical

What are the main milestones and achievements of Daewoong’s pharmaceutical business over its decades of evolution? Daewoong was first…

Interview with Federico Seghi Recli , Managing Director, Molteni

Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international…

Interview with Martin Soeters, President, Novo Nordisk Europe

Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the…

Interview with Socorro España Lomeli, Executive Officer, ANAFAM

This is your 3rd interview with Focus Reports. What would you say has been the biggest change that has shaped the pharmaceutical industry since we…

Tagged with